Latest Breaking News On - Clinical events committee - Page 8 : comparemela.com

CorFlow Therapeutics AG: CorFlow Announces Positive Data from the MOCA I First in Human Study Presented at EuroPCR 2023

Novel CoFI device found to be safe and highly effective in detecting coronary microvascular obstruction (MVO) in the cathlab immediately after primary PCI CorFlow Therapeutics AG, a clinical-stage

United statesNew yorkFrance generalPaul meadAzeem latibMartin rothmanGewinn nurJudy gonzalezRob schwartzMarco valgimigliClinical events committeeCardiocentro ticino institute in luganoMontefiore medical centerMicrovascular obstructionBreaking trialBusiness wire

CorFlow Announces Positive Data from the MOCA I First in Human Study Presented at EuroPCR 2023

CorFlow Announces Positive Data from the MOCA I First in Human Study Presented at EuroPCR 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesNew yorkFrance generalMartin rothmanPaul meadJudy gonzalezMarco valgimigliRob schwartzAzeem latibCardiocentro ticino institute in luganoMontefiore medical centerClinical events committeeMicrovascular obstructionBreaking trialBusiness wireClinical events

Sequana Medical announces positive top-line results from the North American pivotal alfapump® study (POSEIDON)

Sequana Medical announces positive top-line results from the North American pivotal alfapump® study (POSEIDON)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesHong kongUnited kingdomCian crosbieFlorence wongMary clarkNick bastinUniversity of torontoStrategic communicationsCompany or sequanaClinical events committeeUniversity of toronto onWall streetPre market approvalNorth americaLiver meeting

Sequana Medical NV: Sequana Medical announces positive top-line results from the North American pivotal alfapump study (POSEIDON)

PRESS RELEASEREGULATED INFORMATION - INSIDE INFORMATION25 October 2022, 07:00 am CET alfapump achieves pre-specified primary effectiveness endpoints with statistical significance

United statesHong kongUnited kingdomCian crosbieFlorence wongMary clarkNick bastinUniversity of torontoStrategic communicationsCompany or sequanaClinical events committeeUniversity of toronto onPre market approvalNorth americaLiver meetingEuronext brussels

Data from Roll-In Cohort of North American pivotal alfapump® study (POSEIDON) selected for poster presentation at AASLD The Liver Meeting®

Data from Roll-In Cohort of North American pivotal alfapump® study (POSEIDON) selected for poster presentation at AASLD The Liver Meeting®
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesHong kongUnited kingdomFlorence wongNick bastinRebecca noonanStrategic communicationsCompany or sequanaClinical events committeeUniversity of toronto onSunday novemberLife in patientsSequana medicalEuronext brusselsRoll in cohortNorth american